Status:
NOT_YET_RECRUITING
Biomarkers in the Endometrial Fluid, Tissue, and Follicular Fluid of Moderate/Severe Endometriosis Patients
Lead Sponsor:
Region Stockholm
Conditions:
Endometriosis
Eligibility:
FEMALE
18-40 years
Brief Summary
This study aims to explore biomarkers in the endometrial fluid and tissue of women with moderate to severe endometriosis, with a specific focus on those involved in pre-receptive endometrium and embry...
Eligibility Criteria
Inclusion
- Age 18-40 years old
- Diagnosed with moderate/severe endometriosis by ultrasound or laparoscopy (patient group)
- Regular menstrual cycles 28-35 days
- Speak English or Swedish and agree to participate in the study
Exclusion
- Pregnancy or lactation in the last 3 months
- Uterine anomalies
- Pelvic inflammatory disease, endometritis, STD
- Gynaecological cancers or other malignancies in the patient's history
- Smoking (more than 10 cigarettes per day) or alcohol abuse
- Immunosuppressing medicines
- Major abdominal or pelvic surgery in the last 3 months
- A specific genetic disease that is diagnosed before PGT in women undergoing treatment
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT07182643
Start Date
October 1 2025
End Date
December 31 2027
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska Institute and Karolinska University Hospital Huddinge
Stockholm, Sweden, 14433